## Abstract The goal of this work was to investigate methods to retain bioactivity of nerve growth factor (NGF) after encapsulation in poly(lacticβ__co__βglycolic acid) (PLGA) discs for controlled release. Poly(ethylene glycol) (PEG) was chosen as a porogen not only to control the release rate of N
β¦ LIBER β¦
Controlled release of bioactive recombinant human growth hormone from PLGA microparticles
β Scribed by Rafi, Md.; Singh, Surinder M.; Kanchan, Vibhu; Anish, C. K.; Panda, Amulya K.
- Book ID
- 111936011
- Publisher
- Informa plc
- Year
- 2010
- Tongue
- English
- Weight
- 443 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0265-2048
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Maintaining bioactivity of NGF for contr
β
Philip J. Johnson; Stacy L. Skornia; Sarah E. Stabenfeldt; Rebecca Kuntz Willits
π
Article
π
2008
π
John Wiley and Sons
π
English
β 181 KB
Release of bioactive human growth hormon
β
Goodwin, C. J. ;Braden, M. ;Downes, S. ;Marshall, N. J.
π
Article
π
1998
π
John Wiley and Sons
π
English
β 239 KB
Development of a novel sustained release
β
Sun Jin Kim; Sei Kwang Hahn; Myung Jin Kim; Duk Hee Kim; Young Phil Lee
π
Article
π
2005
π
Elsevier Science
π
English
β 247 KB
Investigation into the release of bioact
β
Goodwin, C. J. ;Braden, M. ;Downes, S. ;Marshall, N.J.
π
Article
π
1997
π
John Wiley and Sons
π
English
β 264 KB
Previous studies showed that recombinant human growth of their cytotoxicity. The major fraction of the bioactivity was hormone (hGH) released from hormone-loaded poly(methyl-released from both of the PMMA cements during the first methacrylate) (PMMA) cement stimulated osteoid formation 24 h, but the
Controlled release of recombinant insuli
β
Manmohan Singh; Bret Shirley; Kamal Bajwa; Emil Samara; Maninder Hora; Derek OβH
π
Article
π
2001
π
Elsevier Science
π
English
β 169 KB
Development of a sustained-release recom
β
H.H. Kwak; W.S. Shim; M.K. Choi; M.K. Son; Y.J. Kim; H.C. Yang; T.H. Kim; G.I. L
π
Article
π
2009
π
Elsevier Science
π
English
β 723 KB